Just as we suspected, the sketchy Statnews report claiming that Gilead's remdesivir had achieved miraculous results on patients in a small preliminary University of Chicago study has been exposed as complete BS.
The FT just reported that Gilead's "miracle drug" remdesivir has flopped in during its first clinical trial
FT SCOOP: Gilead's potential coronavirus candidate remdesivir has flopped in its first randomised clinical trial, according to draft documents published accidentally by the World Health Organisation and seen by the Financial Times. With @hannahkuchler https://t.co/oGVnfZJox6
— Donato Paolo Mancini (@donatopmancini) April 23, 2020
Stocks are sliding on news that the "miracle drug" is anything but...
(Click on image to enlarge)
....and Gilead shares - which soared nearly 20% on the original Statnews report - are taking it especially hard.
(Click on image to enlarge)
Now, will the mainstream media reporters who slammed Trump following reports that a VA study of hydroxychloroquine suggested it was ineffective?
Someday when the story of this scam is written, I hope it is clear who should be ashamed of themselves for slagging anyone calling for caution: Anti-malarial drug Trump touted is linked to higher rates of death in VA coronavirus patients, study says https://t.co/EKJoGtaRXm
— Kara Swisher (@karaswisher) April 22, 2020
Comments
Log in or sign up to join the conversation.